CD5 and T-cell non-Hodgkin lymphoma: Recent studies in systemic mature T-cell lymphomas, such as those by Elghawy et al. [6], demonstrated that CD5 expression is prevalent in approximately 63 percent of cases and is associated with worse survival outcomes.